4'-methoxy-3-piperidinomethyl benzophenone, 97.0%, 1g

2,3-Dimethoxy-6,6-dimethyl-5,6-dihydrobenzo[7,8]indolizino[2,3-b]quinoxaline, 95.0%, 50mg

2-Bromo-4,6-dimethoxypyridine, 95.0%, 5g

(S)-2-((2-oxo-3-(4-(3-oxomorpholino)phenyl)oxazolidin-5-yl)methyl)isoindoline-1,3-dione, 98%, 10g

Methyl 3-(2-bromoacetyl)benzoate, 95.0%, 5g

2-(methylamino)-1-(pyridin-2-yl)ethan-1-ol, 95.0%, 250mg

1-(3-Hydroxy-2-methylphenyl)ethanone, 95.0%, 250mg

4-Chloro-2-pyridinecarboxylic Acid>96.0%(GC)(T)1g

4-Methoxy-1,2-benzenediamine hydrochloride, 95.0%, 250mg

4-(Dimethylamino)-1-(2-oxopropyl)pyridinium bromide, 250mg

(R)-2-Amino-3-methoxypropanoic acid, 95.0%, 10g

GC capillary column ROTI®Cap-5, 10 m, 0.25 mm, 0.25 µm, 1 Piece(s)

(R)-tert-Butyl 2-(2-hydroxyethyl)piperazine-1-carboxylate hydrochloride, 95.0%, 100mg